Michelle Roytman
Overview
Explore the profile of Michelle Roytman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
273
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Keir G, Roytman M, Mashriqi F, Shahsavarani S, Franceschi A
AJNR Am J Neuroradiol
. 2024 Aug;
45(12):1865-1877.
PMID: 39209485
Atypical parkinsonian syndromes, also known as Parkinson-plus syndromes, are a heterogeneous group of movement disorders, including dementia with Lewy bodies (DLB), progressive supranuclear palsy (PSP), multisystem atrophy (MSA), and corticobasal...
2.
Sung J, Lin M, Giantini-Larsen A, Kim A, Edasery D, Roytman M, et al.
World Neurosurg
. 2024 Jul;
187:294-303.
PMID: 38970200
The confirmation of cerebrospinal fluid (CSF) leaks in the setting of spontaneous intracranial hypotension (SIH) by imaging involves a growing toolset of multimodal advanced spinal and skull base imaging techniques,...
3.
Kim J, Chang S, Haghdel A, Ramakrishna R, Pannullo S, Schwartz T, et al.
AJNR Am J Neuroradiol
. 2024 Apr;
45(6):773-780.
PMID: 38604734
Background And Purpose: WHO grade 3 meningiomas are rare and poorly understood and have a higher propensity for recurrence, metastasis, and worsened clinical outcomes compared with lower-grade meningiomas. The purpose...
4.
Ivanidze J, Chang S, Haghdel A, Kim J, Roy Choudhury A, Wu A, et al.
Neuro Oncol
. 2024 Mar;
26(8):1526-1535.
PMID: 38553990
Background: Our purpose was to determine the utility of [68Ga]-DOTATATE PET/MRI in meningioma response assessment following radiosurgery. Methods: Patients with meningioma prospectively underwent postoperative DOTATATE PET/MRI. Co-registered PET and gadolinium-enhanced...
5.
McMahon P, Pisapia D, Schweitzer A, Heier L, Souweidane M, Roytman M
Radiol Case Rep
. 2023 Nov;
19(1):414-417.
PMID: 38028299
The central nervous system (CNS) is a rare but serious site of tuberculosis spread that manifests in three forms: meningitis, spinal arachnoiditis, and CNS tuberculoma. CNS tuberculoma, or intracranial tuberculous...
6.
Rohatgi V, Robbins M, Roytman M, Chazen J
Curr Pain Headache Rep
. 2023 Sep;
27(11):685-693.
PMID: 37688759
Purpose Of Review: Spontaneous intracranial hypotension (SIH) is a debilitating disease typically featuring orthostatic headache and caused by a spinal CSF leak. This review will describe the characteristics of SIH...
7.
Mahase S, Roytman M, Roth OBrien D, Ivanidze J, Schwartz T, Pannullo S, et al.
Cancer Rep (Hoboken)
. 2023 Feb;
6(7):e1788.
PMID: 36750401
Background: Clinical trials evaluating immune checkpoint inhibition (ICI) in recurrent high-grade gliomas (rHGG) report 7%-20% 6-month progression-free survival (PFS), while re-irradiation demonstrates 28%-39% 6-month PFS. Aims: We evaluate outcomes of...
8.
Spano M, Roytman M, Aboian M, Saboury B, Franceschi A, Chiang G
PET Clin
. 2022 Nov;
18(1):103-113.
PMID: 36442959
Alzheimer disease (AD) is the most common cause of dementia, accounting for 50% to 60% of cases and affecting nearly 6 million people in the United States. Definitive diagnosis requires...
9.
Roytman M, Mashriqi F, Al-Tawil K, Schulz P, Zaharchuk G, Benzinger T, et al.
AJR Am J Roentgenol
. 2022 Nov;
220(4):562-574.
PMID: 36321981
Amyloid-related imaging abnormalities (ARIA) is a term introduced in 2010 to encompass a spectrum of MRI findings observed in patients receiving investigational anti-amyloid beta (Aβ) immunotherapies for Alzheimer disease (AD)....
10.
Parasram M, Roytman M, Lee A, Ivanidze J
J Osteopath Med
. 2022 Aug;
123(1):55-56.
PMID: 35998653
No abstract available.